RLM - Realm Therapeutics Plc

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue253.341,120.84866.9371,232.593
Cost of Revenue--120.906240.729
Gross Profit253.341,120.84746.031991.864
Operating Expenses
Research Development8,570.2588,189.1965,049.0431,792.971
Selling General and Administrative4,906.7723,622.7963,003.914,391.409
Non Recurring----
Others----
Total Operating Expenses13,477.0311,811.9928,173.8596,425.109
Operating Income or Loss-13,223.69-10,691.152-7,306.922-5,192.516
Income from Continuing Operations
Total Other Income/Expenses Net-399.36658.0822.875-12.089
Earnings Before Interest and Taxes-13,223.69-10,691.152-7,306.922-5,192.516
Interest Expense----12.089
Income Before Tax-13,623.056-10,633.07-7,304.047-5,204.605
Income Tax Expense4.1-107.68726.61234.004
Minority Interest----
Net Income From Continuing Ops-13,627.156-10,525.383-7,330.659-5,238.609
Non-recurring Events
Discontinued Operations--6,823.418-4,134.839
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-13,627.156-10,525.383-507.241-9,373.448
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-13,627.156-10,525.383-507.241-9,373.448